Login

Biocon Ltd.

₹324.4

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Biocon Ltd.

₹324.4

₹324.4

5.55 (1.74%) - 30 Apr 2025 01:45 PM

About Company

Biocon Limited is engaged in the manufacture of biotechnology products and research services. It is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Market Cap. ₹38,281 Cr.
52 Week - High/Low ₹405/270
P/E Ratio 63.52
P/B Ratio 3.51
Enterprise Value ₹39,853 Cr.
ROE % 1.1
RSI Value 43.96
EMA 50 335.04
EMA 200 338.54
Market Cap. ₹38,281 Cr.
52 Week - High/Low ₹405/270
P/E Ratio 47.59
P/B Ratio 1.94
Enterprise Value ₹51,142 Cr.
ROE % 7.0
RSI Value 43.96
EMA 50 335.04
EMA 200 338.54
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.